Cell Reports (Apr 2023)

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1

  • Yi-Kang Wang,
  • Ning Ma,
  • Sheng Xu,
  • Jing-Yi Huang,
  • Qian-Zhi Ni,
  • Hui-Jun Cao,
  • Qian-Wen Zheng,
  • Bing Zhu,
  • Ji Xia,
  • Feng-Kun Zhang,
  • Xu-Fen Ding,
  • Xiao-Song Qiu,
  • Tian-Wei Chen,
  • Kang Wang,
  • Wei Chen,
  • Zhi-Gang Li,
  • Shu-Qun Cheng,
  • Dong Xie,
  • Jing-Jing Li

Journal volume & issue
Vol. 42, no. 4
p. 112340

Abstract

Read online

Summary: Pancreatic progenitor cell differentiation and proliferation factor (PPDPF) has been reported to play a role in tumorigenesis. However, its function in hepatocellular carcinoma (HCC) remains poorly understood. In this study, we report that PPDPF is significantly downregulated in HCC and the decreased PPDPF expression indicates poor prognosis. In the dimethylnitrosamine (DEN)-induced HCC mouse model, hepatocyte-specific depletion of Ppdpf promotes hepatocarcinogenesis, and reintroduction of PPDPF into liver-specific Ppdpf knockout (LKO) mice inhibits the accelerated HCC development. Mechanistic study shows that PPDPF regulates nuclear factor κB (NF-κB) signaling through modulation of RIPK1 ubiquitination. PPDPF interacts with RIPK1 and facilitates K63-linked ubiquitination of RIPK1 via recruiting the E3 ligase TRIM21, which catalyzes K63-linked ubiquitination of RIPK1 at K140. In addition, liver-specific overexpression of PPDPF activates NF-κB signaling and attenuates apoptosis and compensatory proliferation in mice, which significantly suppresses HCC development. This work identifies PPDPF as a regulator of NF-κB signaling and provides a potential therapeutic candidate for HCC.

Keywords